Construction and Verification of Risk Predictive Nomogram in Patients of Connective Tissue Disease with Severe Pneumonia

构建和验证伴有重症肺炎的结缔组织病患者风险预测列线图

阅读:1

Abstract

PURPOSE: To construct Risk Predictive Nomogram in patients of connective tissue disease (CTD) with severe pneumonia. METHODS: Eighty CID patients with severe pneumonia in rheumatology and respiratory department of chongqing University Three Gorges hospital from January 2020 to December 2022 were retrospectively reviewed and analyzed. Independent risk factors for severe pneumonia in CTD were screened by univariate and binomial logistic regression analysis. The nomogram was constructed by R software. Area under the curve (AUC) of receiver operating characteristic (ROC) was used to evaluate the nomogram's discrimination, and the calibration curve and Hosmer-Lemeshow test were used to reflect the nomogram's calibration. RESULTS: The study cohort was including 48 patients in the general pneumonia group and 32 patients in the severe pneumonia group. The model variables included Ln CD4/CD8, Ln CRP, Ln PCT and Ln IFN-γ. Hosmer-lemeshow test P value less than 0.05 (χ2 = 7.753, P = 0.458), the area under ROC curve of nomogram was 0.9084 (95% CI: 0.8461-0.9707), and the optimal cutoff value of nomogram was 0.490, the sensitivity was 0.872, the specificity was 0.848. In a retrospective study design, 50 patients with CTD complicated with pneumonia admitted to the same hospital from January to June 2023 were selected to verify the model. The nomogram verification results showed Hosmer-Lemeshow test (χ2 = 7.1171, P = 0.5241), AUC value was 0.8958 (95% CI: 0.808-0.9837), and optimal cutoff value was 0.664, the sensitivity was 0.988, the specificity was 0.812. CONCLUSION: The prediction nomogram in this study is helpful for clinical staffs to screen high-risk patients with severe pneumonia in CTD, and has high clinical application value.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。